DiaSorin S.p.A.
Other OTCTotal Valuation
DiaSorin S.p.A. carries a market capitalization of 3.84B, placing it among publicly traded companies globally. Its enterprise value stands at 4.78B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.84B |
| Enterprise Value | 4.78B |
Valuation Ratios
DiaSorin S.p.A. trades at a trailing price-to-earnings ratio of 33.25.
| PE Ratio | 33.25 |
| PS Ratio | 5.37 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | 19.88 |
| P/OCF Ratio | 19.88 |
Enterprise Valuation
On an enterprise value basis, DiaSorin S.p.A. trades at an EV/EBITDA multiple of 24.19 and an EV/FCF ratio of 19.88. The EV/Sales ratio of 5.37 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 24.19 provides insight into valuation relative to core operating earnings.
| EV / Sales | 5.37 |
| EV / EBITDA | 24.19 |
| EV / EBIT | 24.19 |
| EV / FCF | 19.88 |
Financial Position
DiaSorin S.p.A. maintains a current ratio of 6.19, meaning it holds 6.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 6.19 |
| Quick Ratio | 2.07 |
| Debt / Equity | 141.28 |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | 20.05 |
| Return on Capital Employed (ROCE) | 47.77 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, DiaSorin S.p.A. has paid 38.24M in income taxes, reflecting an effective tax rate of 21.21.
| Income Tax | 38.24M |
| Effective Tax Rate | 21.21 |
Stock Price Statistics
DiaSorin S.p.A.'s stock has declined approximately -27.95319% over the past 52 weeks. The 50-day moving average sits at 75.87, while the 200-day moving average is 76.90.
| Beta (5Y) | N/A |
| 52-Week Price Change | -27.95319% |
| 50-Day Moving Average | 75.87 |
| 200-Day Moving Average | 76.90 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, DiaSorin S.p.A. generated 891.42M in revenue and converted that into 143.86M in net income, yielding earnings per share of 2.68. EBITDA reached 197.75M, while operating income came in at 197.75M.
| Revenue | 891.42M |
| Gross Profit | 585.12M |
| Operating Income | 197.75M |
| Pretax Income | 180.25M |
| Net Income | 143.86M |
| EBITDA | 197.75M |
| EBIT | 197.75M |
| Earnings Per Share (EPS) | 2.68 |
Cash Flow
DiaSorin S.p.A. produced 240.58M in operating cash flow over the past twelve months.
| Operating Cash Flow | 240.58M |
| Capital Expenditures | N/A |
| Free Cash Flow | 240.58M |
| FCF Per Share | 4.51 |
Margins
DiaSorin S.p.A. operates with a gross margin of 65.64, reflecting its pricing power and cost economics. The operating margin of 22.18 and net profit margin of 16.14 provide insight into operational efficiency.
| Gross Margin | 65.64 |
| Operating Margin | 22.18 |
| Pretax Margin | 20.22 |
| Profit Margin | 16.14 |
| EBITDA Margin | 22.18 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 4.47 |
| FCF Yield | 5.03 |
Scores
DiaSorin S.p.A. posts an Altman Z-Score of 6.72, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 6.72 |